New India Rule Could Require Drug To Stay on Market For 18 More Months
This article was originally published in PharmAsia News
Executive Summary
Drug makers selling any of the 348 drugs on India's list of essential medicines may be locked into producing those drugs for at least another 18 months whether they want to or not.